Skip to content

Vidi Gouthro

Royal Ottawa Health Care Group/Registered Nurse / Infirmière autorisée

2025 Salary

$111,998

Total compensation $112,430, including $432 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2025

Employer Rank

#340

Royal Ottawa Health Care Group

Years on List

4

2022–2025

Peak Salary

$111,998

2025

Full 2025 roster at Royal Ottawa Health Care Group →·See where $111,998 ranks →

Total Compensation History

Total compensation by yearLine chart of 4 yearly values of total compensation, from $101,193 in 2022 to $112,430 in 2025.$100K$103K$105K$108K$110K$113K2022202320242025
Total compensation, 2022–2025. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
2022–2025

$100,545 in 2022 is worth about $109,190 in 2025 dollars.

Take-Home Pay
(After Tax) · 2025 estimate

Take-home on Vidi Gouthro's 2025 salary of $111,998 comes to roughly $82,120 once federal and Ontario income tax (about 21.8% effective) is deducted. That is about 3% more than the $108,735 paid in 2024. Records under this name have appeared on the Sunshine List 4 years in all, first in 2022. Pension contributions — likely HOOPP in the Hospitals & Boards of Public Health sector — would typically trim another 7–10% off that figure.

Estimated net pay
~$82,120
Effective income-tax rate (excl. CPP/EI)
~21.8%
CPP + EI contributions
~$5,507
All-in deduction rate (incl. CPP/EI)
~26.7%
vs. 2025 Registered Nurse median
−5%

Where does $111,998 rank on the Sunshine List? →

Estimate only: 2025 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Royal Ottawa Health Care Group
2025

View all 513 employees at Royal Ottawa Health Care Group (2025) →